Under the agreement, Mediterranea gained rights to sell DiaSys’ equipments in Singapore, Malaysia, Indonesia, Vietnam, and Cambodia. Mediterranea CEO Livio Orsini Gravina said the company understands that increased
Zyclara can detect and eliminate subclinical as well as clinical AK lesions on large areas of the skin. Zyclara has shown to be an effective therapy in eliminating
The compound patent provides protection for Alimta in the US through January of 2017. Lilly senior vice president and general counsel Robert Armitage said the company is delighted
The open-label, dose-escalation trial will enroll up to 40 patients at multiple centers in the US who have previously been treated with one or two tyrosine kinase inhibitors
POWDER BURN, the first product in the new blaqseries, is the pre-workout available with no banned substances for military personnel which provides energy, mental focus and stamina without
The Phase III trial was designed to compare prasugrel plus aspirin to clopidogrel plus aspirin in the patient population in acute coronary syndrome unstable angina (UA)/ non-ST elevation
The contracts include a two-year application management outsourcing engagement for a university-affiliated children’s hospital and business process re-engineering and application implementation services for a regional health insurer for
The EHR also makes it possible for customers to schedule appointments and supports real-time medical billing. Walgreens senior vice president and chief information officer Tim Theriault said with
The toolkit forms the basis of an Imaging Biomarker Information System (IBIS), which provides computer-assisted diagnosis (CAD) of the lung from CT for early diagnosis, treatment planning and
FDA after consultations with the Genzyme has asked it to modify the data sets presentation to enable the agency to process the application. The FDA has not requested
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.